Source: Wikipedia

South Beach Recipes – Two Popular South Beach Recipes

With summer coming up, a lot of people try to look their best � slim and toned up. As a result, a lot of people are looking for that little extra support to help them lose weight and look the best.
In order to have a nice summer-look body, one needs to start exercising and eating well several months before summer sets on. Exercising and a balanced diet and healthy diet is what you need. To diet, you can use various diet plans and recipes, and South Beach Recipes is one of them.

As popularity of the South Beach Diet increases, many South Beach Recipes are being formulated and to help those who love to make their body fit and slim.

South Beach Recipes are proven to be rich and satisfying South Beach Recipes that are now include in most South Beach Diet menus. So what can you benefit from following the South Beach Recipes?

The seSouth Beach Recipes are chosen from the South Beach Diet Cookbook, and are delicious, flavorful, easy to prepare, appetizing enough to spice up any mealtime, and most of all these South Beach Recipes are good for you. These South Beach Recipes focus on fresh, lean protein, seasonal produce, and heart-healthy fats just like the olive oil. South Beach Recipes are therefore perfect for a weekday family dinner.

Here are two popular South Beach Recipes for you to try today.
Read the rest of this entry »

Looking to make a change and lose some weight? I have reviewed the top diet on the internet and you can go and read over 200 comments people have made about why this diet has worked well for them, as well as some of the problems.

Tags: balanced diet, Beef, diet plans, healthy diet, London, oil, olive oil, Pepper Salad, South Beach Diet, south beach recipes, virgin olive oil

A report was released yesterday from the Kings College of London and although the details are tough to find right now on the internet, the study still shows a lot of evidense that drinking tea is very good for you. Drinking three or more cups of tea a day is as good for you as drinking plenty of water and may even have extra health benefits, say researchers.

The work in the European Journal of Clinical Nutrition dispels the common belief that tea dehydrates. Tea not only rehydrates as well as water does, but it can also protect against heart disease and some cancers, UK nutritionists found.

Experts believe flavonoids are the key ingredient in tea that promote health. These polyphenol antioxidants are found in many foods and plants, including tea leaves, and have been shown to help prevent cell damage. Tea replaces fluids and contains antioxidants so its got two things going for it. Public health nutritionist Dr Carrie Ruxton, and colleagues at Kings College London, looked at published studies on the health effects of tea consumption.

They found clear evidence that drinking three to four cups of tea a day can cut the chances of having a heart attack. Some studies suggested tea consumption protected against cancer, although this effect was less clear-cut. Other health benefits seen included protection against tooth plaque and potentially tooth decay, plus bone strengthening.
Read the rest of this entry »

Tags: British Nutrition Foundation, cancer, cancers, Carrie Ruxton, Claire Williamson, food, heart attack, heart disease, Kings College, Kings College London, London, Public health nutritionist, Tea Council, the European Journal, United Kingdom

My wife has been taking high dosages of aspirin tow or three times a day for the last few months as she had some clots show up on her legs and the doctor, after having me give her injections to thin her blood, gave her this prescrition for a generic type of aspirin derivative that she is taking. As always I scoured the internet to find more information on taking aspirin and I have copied the following info from both Wikipedia and the FDA in case you have a simeilar interest. The wiki info is an outline on aspirin itself and the FDA info is a bunch of questions and answers about aspirin.

Aspirin or acetylsalicylic acid (acetosal) is a drug in the family of salicylates, often used as an analgesic (against minor pains and aches), antipyretic (against fever), and anti-inflammatory. It has also an anticoagulant (”blood-thinning”) effect and is used in long-term low-doses to prevent heart attacks.

Low-dose long-term aspirin irreversibly blocks the formation of thromboxane A2 in platelets, producing an inhibitory effect on platelet aggregation, and this blood-thinning property makes it useful for reducing the incidence of heart attacks. Aspirin produced for this purpose often comes in 75 or 81 mg dispersible tablets and is sometimes called “Junior aspirin”. High doses of aspirin are also given immediately after an acute heart attack. These doses may also inhibit the synthesis of prothrombin and may therefore produce a second and different anticoagulant effect.

Several hundred fatal overdoses of aspirin occur annually, but the vast majority of its uses are beneficial. Its primary undesirable side effects, especially in stronger doses, are gastrointestinal distress (including ulcers and stomach bleeding) and tinnitus. Another side effect, due to its anticoagulant properties, is increased bleeding in menstruating women. Because there appears to be a connection between aspirin and Reye’s syndrome, aspirin is no longer used to control flu-like symptoms in minors.[1]

Aspirin was the first discovered member of the class of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs), not all of which are salicylates, though they all have similar effects and a similar action mechanism.
Read the rest of this entry »

Tags: A. Consumers, A. Patients, acetyl group, aches, allergy, angina pectoris, angioplasty, arthritis, Arthur Eichengr, Arthur Eichengrun, aspirin, aspirin products, Asthma, Bayer, body systems, British Columbia, bypass, Cerebral Ischemia, Charles Frederic Gerhardt, chemical, chemical structure, chemist, chest pain, chills, coronary artery disease, Cox, Department of Pharmaceutical Sciences, Derek W. Gilroy, diarrhea, Egypt, fda, fever, first discovered member, Friedrich Bayer & Co., Gerhardt, Germany, Glasgow, headaches, hearing loss, heart attack, heart attacks, Henri Leroux, Heyden Company, high blood pressure, Hoffmann, hydroxyl functional groups, ibuprofen, ISIS, John Robert Vane, juvenile rheumatoid arthritis, ketoprofen, kidney disease, London, Michigan, myocardial infarctions, osteoarthritis, pain, pains, pharmaceuticals industry, pharmacist, physician, pleurisy, Raffaele Piria, research assistant, researcher, Reye's syndrome, rheumatism, rheumatoid arthritis, Royal College of Surgeons in London, selective inhibitors, spondylarthropathies, stroke, Stroke Prevention, strokes, Sumeria, systemic lupus erythematosus, thrombus, tinnitus, transient ischemic attack, treatment of cardiovascular and cerebrovascular diseases, United Kingdom, United States, University of Strathclyde in Glasgow, unstable angina, Walter Sneader

What is Glivec? It seems that w3e always hear cancer storeis and that there are not very many good news stories, not that I usually see anyway. Leukemia is a type of blood cancer that is often fatal and I had not ever heard of any drug therapies that were remarkable until I saw a news result today out of England that said that many people taking the drug Glivec are having amazing results. Here is some info on this Drug from Medical News Today.

Most patients who develop chronic myeloid leukaemia (CML) can now expect to live more than 20 years from diagnosis if they are treated with the tyrosine kinase inhibitor (TKI) Glivec (imatinib) according to haematologists involved in the IRIS (International Randomized Interferon versus STI571) study. Before availability of current treatments, median survival from diagnosis was 3.5 years.

Around 95 per cent of patients diagnosed with CML have the Philadelphia chromosome positive (Ph+) form that responds well to Glivec, said Professor John Goldman, professor of haematology at Imperial College, London. The chromosome is the result of translocation between the long arms of chromosomes 9 and 22. Part of the breakpoint cluster region (Bcr) gene from chromosome 22 fuses with part of the abelson leukaemia virus (Abl) gene on chromosome 9 producing the abnormal tyrosine kinase protein Bcr-Abl. It is this protein that causes the proliferation of white blood cells resulting in CML.

Four-year data from IRIS were presented at this year’s American Society of Hematology (ASH) meeting. More than 90 per cent of patients with Ph+ CML in the chronic phase, randomised initially to Glivec 400mg daily in the year 2000, were still alive and free of progression to advanced disease at 54 months, Professor Goldman said.

The study confirmed that patients who achieved a major molecular response within one year, ie, a more than 1000-fold reduction in residual leukaemia, fared best. Patients achieving a three-log reduction in Bcr-Abl transcript levels within oneyear were all free of progression to advanced disease at year four.
Read the rest of this entry »

Tags: advanced disease, American Society of Hematology, cancer, Chairman, diabetes, drug therapies, France, Francois Guilhot, Glivec What, Glivec-resistant, Hagop Kantarjian, Imperial College, John Goldman, leukaemia, Leukemia, London, Novartis, Philadelphia, professor, professor of haematology, professor of oncology, Texas, United Kingdom, University of Poitiers